1,496 results on '"Birnie, David"'
Search Results
2. Risk Stratification in Cardiac Sarcoidosis With Cardiac Positron Emission Tomography: A Systematic Review and Meta-Analysis
3. Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation: Insights From ARTESiA
4. Screening tools for the detection of clinically silent cardiac sarcoidosis
5. What is this image? 2023 Image 6 result: 18F-FDG PET in a patient with cardiac sarcoidosis and hibernating myocardium: A case report
6. Adherent skin barrier drape use is associated with a reduced risk of cardiac implantable device infection: Results from a prospective study of 14,225 procedures
7. Do barrier dressings reduce cardiac implantable device infection: Protocol for a randomized controlled trial (BARRIER-PROTECT)
8. Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial
9. An International Survey of Current Clinical Practice in the Treatment of Cardiac Sarcoidosis
10. Incidence of Atrial Fibrillation as the Initial Manifestation of Cardiac Sarcoidosis: Insights From a Catheter Ablation Registry
11. Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document.
12. Metabolic activity of the left and right atria are differentially altered in patients with atrial fibrillation and LV dysfunction
13. Outcomes of a comprehensive strategy during repeat atrial fibrillation ablation
14. A Randomized Trial of Lenient Versus Strict Arm Instruction Post Cardiac Device Surgery (LENIENT)
15. Cardiac Sarcoidosis
16. Interleukin-1 Blockade in Cardiac Sarcoidosis: A Pilot Study
17. Development of a Mouse Cardiac Sarcoidosis Model Using Carbon Nanotubes
18. Clinical outcomes of the AdaptResponse trial – Authors' reply
19. Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale
20. Augmented wide area circumferential catheter ablation for reduction of atrial fibrillation recurrence (AWARE) trial: Design and rationale
21. Should they stay, or should they go: Do we need to remove the old cardiac implantable electronic device if a new system is required on the contralateral side?
22. Cardiac sarcoidosis
23. Cardiac sarcoidosis with extensive and heterogeneous left ventricular FDG uptake in absence of guidelines indication for an implantable defibrillator: Ventricular tachycardia precipitated by immunosuppressive therapy, should we have done differently?
24. Prognostic Information From Endocardial Voltage Mapping at the Time of Endomyocardial Biopsy for the Diagnosis of Cardiac Amyloidosis
25. Adverse Events Associated With Electrical Cardioversion in Patients With Acute Atrial Fibrillation and Atrial Flutter
26. Prognostic Value of Low Voltage Area Burden in Atrial Fibrillation
27. Management of ventricular tachycardia in patients with cardiac sarcoidosis
28. A randomized, controlled comparison of electrical versus pharmacological cardioversion for emergency department patients with acute atrial flutter
29. Atypical Presentation of Cardiac Sarcoidosis and the Role of Multimodality Imaging
30. Catheter Ablation of Low-Voltage Areas for Persistent Atrial Fibrillation: Procedural Outcomes Using High-Density Voltage Mapping
31. High-power short-duration radiofrequency ablation of typical atrial flutter
32. Current perspectives on the immunopathogenesis of sarcoidosis
33. Do We Need Heart Teams for Complex Cardiac Arrhythmias? A Cardiologist’s Perspective
34. Correction to: Outcomes of a comprehensive strategy during repeat atrial fibrillation ablation
35. Mortality Risk Increases With Clustered Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators
36. Unique cognitive trajectories associated with inflammatory markers of blood‐brain barrier permeability in atrial fibrillation: An analysis of the Cardiovascular Health Study Cohort
37. Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation
38. The role of the host-microbiome and metabolomics in sarcoidosis
39. Reproducibility of cardiac magnetic resonance imaging in patients referred for the assessment of cardiac sarcoidosis; implications for clinical practice
40. Interleukin-1 blockade in cardiac sarcoidosis: study design of the multimodality assessment of granulomas in cardiac sarcoidosis: Anakinra Randomized Trial (MAGiC-ART)
41. Sex differences in CRT device implantation rates, efficacy, and complications following implantation: protocol for a systematic review and meta-analysis of cohort studies
42. Risk Factors for Infections Involving Cardiac Implanted Electronic Devices
43. A Strategy of Lead Abandonment in a Large Cohort of Patients With Sprint Fidelis Leads
44. Left atrial imaging and registration of fibrosis with conduction voltages using LGE-MRI and electroanatomical mapping
45. Adaptive cardiac resynchronization therapy is associated with decreased risk of incident atrial fibrillation compared to standard biventricular pacing: A real-world analysis of 37,450 patients followed by remote monitoring
46. Comparison of Ajmaline and Procainamide Provocation Tests in the Diagnosis of Brugada Syndrome
47. Prevention of Arrhythmia Device Infection Trial: The PADIT Trial
48. The Impact of Cardiac Rehabilitation on Mental and Physical Health in Patients With Atrial Fibrillation: A Matched Case-Control Study
49. High‐power short‐duration versus low‐power long‐duration ablation for pulmonary vein isolation: A substudy of the AWARE randomized controlled trial.
50. PO-05-175 THE TEMPORAL RELATIONSHIP BETWEEN VENTRICULAR ARRHYTHMIAS AND MORTALITY: INSIGHTS FROM THE RESYNCHRONIZATION IN AMBULATORY HEART FAILURE TRIAL (RAFT)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.